Comparison of urinary 8-hydroxy-2'-deoxyguanosine in patients treated with topical corticosteroids, UV-B, and psoralen UV-A therapies.
Goldstein
A E
AE
Lebwohl
M
M
Wei
H
H
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004249:DNA Damage; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000652:urine; D005260:Female; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000628:therapy* / Q000652:urine; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D011701:PUVA Therapy; D011565:Psoriasis / Q000628:therapy* / Q000652:urine; D014467:Ultraviolet Therapy / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000080242:8-Hydroxy-2'-Deoxyguanosine; D003849:Deoxyguanosine